Piramal buys US pharma co. Minrad for US40 mn

摘要

Piramal Healthcare (PHL) has acquired US-based pharmaceutical company, Minrad International, for US40-mn (Rs. 188-crore). The move is expected to help PHL get immediate access into the US market for sevoflurane, the largest selling inhalation anesthetic in the US. PHL has also had a distribution and marketing agreement with the US-based company for domestic and international markets.